- Home
- /
- News
- /
- Pharmacology/ Therapeutics
- /
- October 2011
Pharmacology/ Therapeutics News for October 2011
A comprehensive database developed by King’s College London researchers that features the chemical components found in traditional Chinese medicines has been released to market this month, enabling researchers to explore age-old remedies in the search for tomorrow’s new drugs.
21 October, 2011
DiaGenic reports preliminary positive findings from the collaborative R&D project with Pfizer Inc. where the objective is to identify blood-based biomarkers that may be useful in diagnosing and monitoring Alzheimer’s disease.
19 October, 2011
Roche announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer’s disease.
12 October, 2011
Six new genetic variants will help identify diagnostic markers and drug targets for the 55 million Asian’s affected.
11 October, 2011
New research released today to mark European Week Against Pain reveals that, in more than half of cases, peoples’ levels of pain across Europe are not being adequately assessed.
10 October, 2011
Sanford-Burnham scientists reveal that a hormone called orexin prevents obesity in mice by activating brown fat, a tissue that’s good at burning calories.
06 October, 2011
A study published in Nature online today (Dawson et al. Advanced online Publication, DOI: 10.1038/nature10509) by Cellzome and others has identified that a small molecule inhibitor of BET proteins could potentially be used to treat the aggressive and often incurable mixed lineage (MLL-fusion) leukaemia.
03 October, 2011
Cancer Research Technology (CRT), Cancer Research UK’s commercial arm, has established a group of scientists with expertise in lipid metabolism – getting energy from fats and making building blocks for cell growth – to develop targets for potential new cancer drugs.
03 October, 2011